Changing in CDR3 size patterns associated with autologous GVHD before ASCT (upper) and day 26 after ASCT at the onset of autologous GVHD (lower).

CDR3 size patterns of PBLs in the patients who did not receive CsA (control; panel A) and those in whom autologous GVHD developed (patients 3 and 23; panels B and C, respectively).